BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18097589)

  • 1. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
    Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
    J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.
    Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G
    Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 overexpression is associated with angiogenesis in ovarian cancer.
    Lin YG; Han LY; Kamat AA; Merritt WM; Landen CN; Deavers MT; Fletcher MS; Urbauer DL; Kinch MS; Sood AK
    Cancer; 2007 Jan; 109(2):332-40. PubMed ID: 17154180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of angiogenesis in paediatric glioblastoma multiforme and its correlation with survival.
    Germanò A; Caffo M; Caruso G; La Rosa G; Galatioto S; Tomasello F
    Childs Nerv Syst; 2001 Oct; 17(10):577-83. PubMed ID: 11685518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
    Pen A; Moreno MJ; Martin J; Stanimirovic DB
    Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
    Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
    Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
    Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma.
    Liu F; Park PJ; Lai W; Maher E; Chakravarti A; Durso L; Jiang X; Yu Y; Brosius A; Thomas M; Chin L; Brennan C; DePinho RA; Kohane I; Carroll RS; Black PM; Johnson MD
    Cancer Res; 2006 Nov; 66(22):10815-23. PubMed ID: 17090523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of diagnostic neuronal markers and outcome in glioblastoma.
    Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
    Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
    J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
    Kinch MS; Moore MB; Harpole DH
    Clin Cancer Res; 2003 Feb; 9(2):613-8. PubMed ID: 12576426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.